Article

Harty, G., Jarrett, J. & Jofre-Bonet, M. ORCID: 0000-0002-2055-2166 (2018). Consequences of Biomarker Analysis on the Cost-Effectiveness of Cetuximab in Combination with FOLFIRI as a First-Line Treatment of Metastatic Colorectal Cancer: Personalised Medicine at Work. Applied Health Economics and Health Policy, doi: 10.1007/s40258-018-0395-5